Hypoproteinemia in cancer patients
Conditions
Interventions
Experimental group:Basic treatment + administration of 20g of dual-protein special diet nutritional powder bid (with a protein mass of approximately 21.0g /d)
Control group:Basic treatment + Yuansu 23 g bid (protein mass approximately 7.3 g/d)
Sponsors
Shanghai Sixth People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The pathological report clearly indicates a solid tumor. 2. The patient has a nutritional risk based on the NRS-2002 score or has decreased prealbumin or RBP. 3. Eligible patients of reproductive age (both male and female) must agree to use reliable contraceptive methods (hormonal or barrier methods or abstinence, etc.) with their partners during the trial and for at least 12 weeks after the last dose. Female patients of childbearing age must have a negative urine pregnancy test within 7 days before the first use of the study drug.
Exclusion criteria
Exclusion criteria: 1. Patients with mental illness or cognitive impairment who are unable to cooperate in filling out the assessment form; 2. Patients with infectious diseases such as AIDS, syphilis, and tuberculosis; 3. Allergy to whey protein.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| General situation;Nutrient intake status;Body composition ;Serological index ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient-generated subjective global assessment,PG-SGA;Metabolic emergency state Scoring;Changes in fecal intestinal flora; | — |
Countries
China
Contacts
Public ContactHaiyan Hu
Shanghai Sixth People's Hospital
Outcome results
None listed